Search Results - "LORUSSO, Vito"

Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs by Comes, Maria Colomba, Fanizzi, Annarita, Bove, Samantha, Didonna, Vittorio, Diotaiuti, Sergio, La Forgia, Daniele, Latorre, Agnese, Martinelli, Eugenio, Mencattini, Arianna, Nardone, Annalisa, Paradiso, Angelo Virgilio, Ressa, Cosmo Maurizio, Tamborra, Pasquale, Lorusso, Vito, Massafra, Raffaella

“…The dynamic contrast-enhanced MR imaging plays a crucial role in evaluating the effectiveness of neoadjuvant chemotherapy (NAC) even since its early stage…”
Get full text

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial by Cunningham, David, Prof, Lang, Istvan, MD, Marcuello, Eugenio, MD, Lorusso, Vito, MD, Ocvirk, Janja, MD, Shin, Dong Bok, MD, Jonker, Derek, MD, Osborne, Stuart, MSc, Andre, Niko, MD, Waterkamp, Daniel, MD, Saunders, Mark P, MD

“…Summary Background Elderly patients are often under-represented in clinical trials of metastatic colorectal cancer. We aimed to assess the efficacy and safety…”
Get full text

Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study by Muscaritoli, Maurizio, Lucia, Simone, Farcomeni, Alessio, Lorusso, Vito, Saracino, Valeria, Barone, Carlo, Plastino, Francesca, Gori, Stefania, Magarotto, Roberto, Carteni, Giacomo, Chiurazzi, Bruno, Pavese, Ida, Marchetti, Luca, Zagonel, Vittorina, Bergo, Eleonora, Tonini, Giuseppe, Imperatori, Marco, Iacono, Carmelo, Maiorana, Luigi, Pinto, Carmine, Rubino, Daniela, Cavanna, Luigi, Di Cicilia, Roberto, Gamucci, Teresa, Quadrini, Silvia, Palazzo, Salvatore, Minardi, Stefano, Merlano, Marco, Colucci, Giuseppe, Marchetti, Paolo

“…In cancer patients, malnutrition is associated with treatment toxicity, complications, reduced physical functioning, and decreased survival. The Prevalence of…”
Get full text

A ultrasound-based radiomic approach to predict the nodal status in clinically negative breast cancer patients by Bove, Samantha, Comes, Maria Colomba, Lorusso, Vito, Cristofaro, Cristian, Didonna, Vittorio, Gatta, Gianluca, Giotta, Francesco, La Forgia, Daniele, Latorre, Agnese, Pastena, Maria Irene, Petruzzellis, Nicole, Pomarico, Domenico, Rinaldi, Lucia, Tamborra, Pasquale, Zito, Alfredo, Fanizzi, Annarita, Massafra, Raffaella

“…In breast cancer patients, an accurate detection of the axillary lymph node metastasis status is essential for reducing distant metastasis occurrence…”
Get full text

Hounsfield unit attenuation value can differentiate pyonephrosis from hydronephrosis and predict septic complications in patients with obstructive uropathy by Boeri, Luca, Fulgheri, Irene, Palmisano, Franco, Lievore, Elena, Lorusso, Vito, Ripa, Francesco, D’Amico, Mario, Spinelli, Matteo Giulio, Salonia, Andrea, Carrafiello, Gianpaolo, Montanari, Emanuele

“…We aimed to assess the role of computerized tomography attenuation values (Hounsfield unit—HU) for differentiating pyonephrosis from hydronephrosis and for…”
Get full text

Metronomic chemotherapy from rationale to clinical studies: A dream or reality? by Gnoni, Antonio, Silvestris, Nicola, Licchetta, Antonella, Santini, Daniele, Scartozzi, Mario, Ria, Roberto, Pisconti, Salvatore, Petrelli, Fausto, Vacca, Angelo, Lorusso, Vito

“…Abstract Metronomic chemotherapy (MC) refers to the close administration of a chemotherapeutic drug for a long time with no extended drug-free breaks. It was…”
Get full text

Sexual-Sparing Robot Assisted Radical Cystectomy in Female: A Step-By-Step Guide by Pacchetti, Andrea, Pignot, Geraldine, Le Quellec, Antoine, Rybikowski, Stanislas, Maubon, Thomas, Branger, Nicolas, Lannes, Francois, Sypre, Davidson, Fakhfakh, Sami, Lorusso, Vito, Rion, Claire, Terrone, Carlo, Walz, Jochen

“…To show different approaches for sexual-sparing robot assisted radical cystectomy in women. Radical cystectomy (RC) is a mainstay treatment for localized…”
Get full text

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX by Ciardiello, F., Normanno, N., Martinelli, E., Troiani, T., Pisconti, S., Cardone, C., Nappi, A., Bordonaro, A.R., Rachiglio, M., Lambiase, M., Latiano, T.P., Modoni, G., Cordio, S., Giuliani, F., Biglietto, M., Montesarchio, V., Barone, C., Tonini, G., Cinieri, S., Febbraro, A., Rizzi, D., De Vita, F., Orditura, M., Colucci, G., Maiello, E., Iaffaioli, Vincenzo, Nasti, Guglielmo, Botti, Gerardo, Tatangelo, F., Chicchinelli, Nicoletta, Montrone, Mirko, Sebastio, Annamaria, Guarino, Tiziana, Simone, Gianni, Graziano, Paolo, Chiarazzo, Cinzia, Di Maggio, Gabriele, Longhitano, Laura, Manusia, Mario, Cartenì, Giacomo, Nappi, Oscar, Micheli, Pietro, Leo, Luigi, Rossi, Sabrina, Cassano, Alessandra, Tommaselli, Eugenio, Giordano, Guido, Sponziello, Francesco, Marino, Antonella, Rinaldi, Antonio, Romito, Sante, Muda, Andrea Onetti, Lorusso, Vito, Leo, Silvana, Barni, Sandro, Grimaldi, Giuseppe, Aieta, Michele

“…Cetuximab plus chemotherapy is a first-line treatment option in metastatic KRAS and NRAS wild-type colorectal cancer (CRC) patients. No data are currently…”
Get full text

Dasatinib: an anti-tumour agent via Src inhibition by Gnoni, Antonio, Marech, Ilaria, Silvestris, Nicola, Vacca, Angelo, Lorusso, Vito

“…Dasatinib (BMS-354825, Sprycel®) is an oral, multitargeted inhibitor of receptor tyrosine kinases (RTKs), including BCR-ABL fusion protein, stem cell factor…”
Get more information

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome by La Forgia, Daniele, Fanizzi, Annarita, Campobasso, Francesco, Bellotti, Roberto, Didonna, Vittorio, Lorusso, Vito, Moschetta, Marco, Massafra, Raffaella, Tamborra, Pasquale, Tangaro, Sabina, Telegrafo, Michele, Pastena, Maria Irene, Zito, Alfredo

“…Contrast-Enhanced Spectral Mammography (CESM) is a recently introduced mammographic method with characteristics particularly suitable for breast cancer…”
Get full text

A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification by Massafra, Raffaella, Comes, Maria Colomba, Bove, Samantha, Didonna, Vittorio, Diotaiuti, Sergio, Giotta, Francesco, Latorre, Agnese, La Forgia, Daniele, Nardone, Annalisa, Pomarico, Domenico, Ressa, Cosmo Maurizio, Rizzo, Alessandro, Tamborra, Pasquale, Zito, Alfredo, Lorusso, Vito, Fanizzi, Annarita

“…Designing targeted treatments for breast cancer patients after primary tumor removal is necessary to prevent the occurrence of invasive disease events (IDEs),…”
Get full text

Machine learning survival models trained on clinical data to identify high risk patients with hormone responsive HER2 negative breast cancer by Fanizzi, Annarita, Pomarico, Domenico, Rizzo, Alessandro, Bove, Samantha, Comes, Maria Colomba, Didonna, Vittorio, Giotta, Francesco, La Forgia, Daniele, Latorre, Agnese, Pastena, Maria Irene, Petruzzellis, Nicole, Rinaldi, Lucia, Tamborra, Pasquale, Zito, Alfredo, Lorusso, Vito, Massafra, Raffaella

“…For endocrine-positive Her2 negative breast cancer patients at an early stage, the benefit of adding chemotherapy to adjuvant endocrine therapy is not still…”
Get full text

A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification by Raffaella Massafra, Maria Colomba Comes, Samantha Bove, Vittorio Didonna, Sergio Diotaiuti, Francesco Giotta, Agnese Latorre, Daniele La Forgia, Annalisa Nardone, Domenico Pomarico, Cosmo Maurizio Ressa, Alessandro Rizzo, Pasquale Tamborra, Alfredo Zito, Vito Lorusso, Annarita Fanizzi

“…Designing targeted treatments for breast cancer patients after primary tumor removal is necessary to prevent the occurrence of invasive disease events (IDEs),…”
Get full text

Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA) by Lorusso, Vito, Russo, Anna, Giotta, Francesco, Codega, Paolo

“…Antineoplastic drugs may induce several side effects, including chemotherapy-induced nausea and vomiting (CINV). Two neurotransmitters play a central role in…”
Get full text

Radiomic Feature Reduction Approach to Predict Breast Cancer by Contrast-Enhanced Spectral Mammography Images by Massafra, Raffaella, Bove, Samantha, Lorusso, Vito, Biafora, Albino, Comes, Maria Colomba, Didonna, Vittorio, Diotaiuti, Sergio, Fanizzi, Annarita, Nardone, Annalisa, Nolasco, Angelo, Ressa, Cosmo Maurizio, Tamborra, Pasquale, Terenzio, Antonella, La Forgia, Daniele

“…Contrast-enhanced spectral mammography (CESM) is an advanced instrument for breast care that is still operator dependent. The aim of this paper is the proposal…”
Get full text

Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer by Vergara, Daniele, PhD, Bellomo, Claudia, MS, Zhang, Xingcai, MS, Vergaro, Viviana, MS, Tinelli, Andrea, MD, Lorusso, Vito, MD, Rinaldi, Ross, PhD, Lvov, Yuri M., PhD, Leporatti, Stefano, PhD, Maffia, Michele, PhD

“…Abstract The sonication-assisted layer-by-layer (SLBL) technology was developed to combine necessary factors for an efficient drug-delivery system: (i) control…”
Get full text

Assessing the cost-effectiveness of waiting list reduction strategies for a breast radiology department: a real-life case study by Fanizzi, Annarita, Graps, Elisabetta, Bavaro, Domenica Antonia, Farella, Marco, Bove, Samantha, Campobasso, Francesco, Comes, Maria Colomba, Cristofaro, Cristian, Forgia, Daniele La, Milella, Martina, Iacovelli, Serena, Villani, Rossella, Signorile, Rahel, De Bartolo, Alessio, Lorusso, Vito, Massafra, Raffaella

“…A timely diagnosis is essential for improving breast cancer patients' survival and designing targeted therapeutic plans. For this purpose, the screening…”
Get full text

A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results by Massafra, Raffaella, Latorre, Agnese, Fanizzi, Annarita, Bellotti, Roberto, Didonna, Vittorio, Giotta, Francesco, La Forgia, Daniele, Nardone, Annalisa, Pastena, Maria, Ressa, Cosmo Maurizio, Rinaldi, Lucia, Russo, Anna Orsola Maria, Tamborra, Pasquale, Tangaro, Sabina, Zito, Alfredo, Lorusso, Vito

“…The mortality associated to breast cancer is in many cases related to metastasization and recurrence. Personalized treatment strategies are critical for the…”
Get full text

Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells by Vergara, Daniele, Valente, Concetta Maria, Tinelli, Andrea, Siciliano, Carlo, Lorusso, Vito, Acierno, Raffaele, Giovinazzo, Giovanna, Santino, Angelo, Storelli, Carlo, Maffia, Michele

“…Highlights ► We show that EGF promotes epithelial–mesenchymal transition in the MCF-7 breast cancer cell line. ► The phenotypic effects are accompanied by…”
Get full text

Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM) by Orlando, Laura, Lorusso, Vito, Giotta, Francesco, Di Maio, Massimo, Schiavone, Paola, Fedele, Palma, Quaranta, Annamaria, Caliolo, Chiara, Ciccarese, Mariangela, Cinefra, Margherita, Romito, Sante, Pisconti, Salvatore, Prete, Salvatore del, Aieta, Michele, Rizzi, Daniele, Maiello, Evaristo, Colucci, Giuseppe, Cinieri, Saverio

“…Background. The combination of chemotherapy plus anti HER-2 agents is the mainstay of HER-2 positive advanced breast cancer (ABC) therapy. We conducted a phase…”
Get full text